Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel

被引：0
作者：
Naoki Fukuda
Yu Fujiwara
Xiaofei Wang
Akihiro Ohmoto
Tetsuya Urasaki
Naomi Hayashi
Yasuyoshi Sato
Kenji Nakano
Mayu Yunokawa
Makiko Ono
Junichi Tomomatsu
Shunji Takahashi
机构：
[1] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Medical Oncology
来源：
European Archives of Oto-Rhino-Laryngology | 2021年 / 278卷
关键词：
Head and neck neoplasms; Carcinoma; Adenoid cystic; Chemotherapy; Prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3037 / 3043
页数：6
相关论文
共 260 条
  • [1] Bjørndal K(2011)Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA) Oral Oncol 47 677-682
  • [2] Krogdahl A(2006)Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies Oral Oncol 42 759-769
  • [3] Therkildsen MH(2004)Adenoid cystic carcinoma of the head and neck: a review Curr Opin Otolaryngol Head Neck Surg 12 127-132
  • [4] Overgaard J(2012)Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973–2007 surveillance, epidemiology, and end results data Cancer 118 4444-4451
  • [5] Johansen J(1997)Adenoid cystic carcinoma of the head and neck Clin Otolaryngol Allied Sci 22 434-443
  • [6] Kristensen CA(2000)Paclitaxel and carboplatin for recurrent salivary gland malignancies Anticancer Res 20 3781-3783
  • [7] Homøe P(2002)Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case report Head Neck 24 406-410
  • [8] Sørensen CH(2016)Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses Acta Otolaryngol 136 948-951
  • [9] Andersen E(2012)Systemic therapy in the management of metastatic or advanced salivary gland cancers Head Neck Oncol 4 19-252
  • [10] Bundgaard T(2014)Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials Clin Cancer Res 20 246-720
12345678910